Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia
暂无分享,去创建一个
E. Neufeld | E. Vichinsky | M. Jonas | N. Olivieri | E. Wright | R. Fischer | P. Harmatz | P. Giardina | J. Kwiatkowski | J. Porter